|
Report No. : |
315101 |
|
Report Date : |
01.04.2015 |
IDENTIFICATION DETAILS
|
Name : |
EMA PHARMA PHARMACEUTICALS |
|
|
|
|
Registered Office : |
Pharma Plaza Building, 4 Asma Fahmy Street, Nozha, Nasr City Cairo |
|
|
|
|
Country : |
Egypt |
|
|
|
|
Financials (as on) : |
31.12.2014 |
|
|
|
|
Date of Incorporation : |
23.09.1996 |
|
|
|
|
Com. Reg. No.: |
298143 |
|
|
|
|
Legal Form : |
Limited Liability Partnership |
|
|
|
|
Line of Business : |
Engaged in the production and marketing of herbal pharmaceutical preparations. |
|
|
|
|
No of Employees : |
110 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – December 31, 2014
|
Country Name |
Previous Rating (30.09.2014) |
Current Rating (31.12.2014) |
|
Egypt |
B2 |
B2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderate Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderate High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EGYPT ECONOMIC OVERVIEW
Occupying the northeast corner of the African continent, Egypt is bisected by the highly fertile Nile valley, where most economic activity takes place. Egypt's economy was highly centralized during the rule of former President Gamal Abdel NASSER but opened up considerably under former Presidents Anwar EL-SADAT and Mohamed Hosni MUBARAK. Cairo from 2004 to 2008 aggressively pursued economic reforms to attract foreign investment and facilitate growth. Poor living conditions combined with limited job opportunities for the average Egyptian contribute to public discontent. After unrest erupted in January 2011, the Egyptian Government backtracked on economic reforms, drastically increasing social spending to address public dissatisfaction, but political uncertainty at the same time caused economic growth to slow significantly, reducing the government's revenues. Tourism, manufacturing, and construction were among the hardest hit sectors of the Egyptian economy, pushing up unemployment levels, and economic growth remains slow amid political uncertainty, government transitions, unrest, and cycles of violence. Cairo since 2011 has drawn down foreign exchange reserves and depended on foreign assistance, particularly from Gulf countries, to finance imports and energy products and prevent further devaluation of the Egyptian pound, fearing higher inflation from a weaker currency.
|
Source
: CIA |
Company Name : EMA PHARMA PHARMACEUTICALS
Also Known As : EMA PHARMA
Country of Origin : Egypt
Legal Form : Limited Liability Partnership
Registration Date : 23rd September 1996
Commercial Registration Number : 298143, Cairo
Tax Card Number : 713-607-696
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
Total Workforce : 110
Activities : Production and marketing of herbal pharmaceutical preparations
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
Person Interviewed : Mohamed Hassan, Financial Controller
COMPANY NAME: EMA PHARMA PHARMACEUTICALS
ALSO KNOWN AS: EMA PHARMA
Building : Pharma Plaza Building
Street : 4 Asma Fahmy Street
Area : Nozha, Nasr City
Town : Cairo
Country : Egypt
Telephone : (20-2) 24177383
/ 24177407
Facsimile : (20-2) 24177383
Mobile : (20-122) 2248040 / (20-100)
1843031 / (20-106) 6600333
Email : info@emapharm.com / emapharm@hotmail.com
Subject operates
from a medium sized suite of offices that are rented and located in the
Suburban Business Area of Cairo.
Branch Office
(s)
Location Description
·
Alexandria Sales
Office
Tel: (20-12) 2464968
·
Mansoura Sales Office
Tel: (20-12) 2467708
·
Sohag Sales Office
Tel: (20-93) 313494
Name Position
·
Dr Ahmed Ahmed
Mohamed Badr Managing
Partner
·
Mohamed Ahmed Mohamed Badr Partner
·
Mohamed
Badr Production
Manager
·
Dr
Mustafa Badr Marketing
Manager
·
Alaa Abd El Moaaty Finance
Manager
·
Mohamed Hassan Financial
Controller
·
Dr Khaled El Zekhary Sales
Manager
Date of Establishment : 23rd
September 1996
Legal Form :
Limited Liability
Partnership
Commercial
Reg. No. : 298143, Cairo
Tax
Card No. : 713-607-696
Issued Capital : £E 500,000
Paid up Capital : £E 500,000
·
Dr Ahmed Ahmed
Mohamed Badr
·
Mohamed Ahmed Mohamed
Badr
Activities: Engaged in the production and marketing of herbal pharmaceutical preparations.
Subject’s products are manufactured at 3rd party facilities
including Pharoania Pharmaceuticals, Amriya pharmaceuticals, Technopharm Egypt,
and R. P Sherer Egypt.
Import
Countries: Canada, United
States of America, China and India
International
Suppliers:
·
Accucaps Canada
·
Sante Naturelle Canada
·
Thera Plantes Canada
·
Flora Canada
·
Jingsu Soho International Group
Corporation China
·
Shaanxi Scidoor Hi-Tech Biology Co Ltd China
·
Hetero Chemicals Ltd India
Brand Names: EMA PHARM
Operating Trend: Steady
Subject has a
workforce of approximately 110 employees.
Financial
highlights provided by local sources are given below:
Currency: Egyptian
Pounds (£E)
Year
Ending 31/12/13: Year Ending
31/12/14:
Total Sales £E 26,315,000 £E 28,700,000
Local sources
consider subject’s financial condition to be Fair.
The above figures
were provided by Mr Mohamed Hassan, Financial Controller
·
Egyptian
American Bank
4 & 6 Hassan Sabri
Zamalek
PO Box: 1825
Cairo
Tel: (20-2) 33416150
Fax: (20-2) 33420265
·
National
Bank of Egypt
24, Sherif Street
Cairo
Tel: (20-2) 33924175
Fax: (20-2) 33924143
No complaints
regarding subject’s payments have been reported.
Local sources
report that the subject’s operating history is clear with payment obligations met
in a generally timely manner. The financial position is satisfactory and the
company is deemed a fair trade risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 62.59 |
|
|
1 |
Rs. 92.45 |
|
Euro |
1 |
Rs. 67.51 |
INFORMATION DETAILS
|
Analysis Done by
: |
KRN |
|
|
|
|
Report Prepared
by : |
DPT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation
is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment record
(10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.